Cargando…
P927: ACTUAL USAGE OF CURRENT SYSTEMIC TREATMENTS AND INFLUENCE OF KEY DRIVERS FOR MULTIPLE MYELOMA IN THE FIRST 2 LINES OF THERAPY. DATA FROM REAL-WORLD STUDY IN EU5 COUNTRIES.
Autores principales: | Blin, Nicolas, Ertl, Siegfried, Schneider, Elodie, Mai, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431017/ http://dx.doi.org/10.1097/01.HS9.0000970612.94379.d8 |
Ejemplares similares
-
927 Laboratory
por: Jeanneret, Guillaume
Publicado: (2014) -
New CCT Magnets in 927
por: Ordan, Julien Marius
Publicado: (2018) -
927 Rifampin for Surgically Treated Staphylococcal Infective Endocarditis
por: Shrestha, Nabin, et al.
Publicado: (2014) -
P927: CLINICAL CHARACTERISTICS, SURVIVAL OUTCOMES AND PROGNOSIS IN 123 IMMUNOGLOBULIN D MULTIPLE MYELOMA PATIENTS: A RETROSPECTIVE SINGLE-CENTER
por: Liu, J., et al.
Publicado: (2022) -
927. Tap Water Avoidance Decreases Rates of Nontuberculous Mycobacteria in Intensive Care Units
por: Baker, Arthur W, et al.
Publicado: (2018)